Outset Medical (NASDAQ:OM) reported second-quarter 2026 revenue of $31.6 million, up 1% from a year earlier and 14% sequentially, as the dialysis technology company cited commercial progress, improving margins and a new $40 million refresh agreement with HCA Healthcare. Chair and Chief Executive Of

Don't let their recent poor performances chase you away.

The hospital juggernaut is adding Texas MedClinic’s locations to its nationwide portfolio of urgent care clinics amid rising consumer demand for fast and convenient medical attention.

HCA Healthcare delivered solid results in the second quarter, with revenue and earnings per share both ahead of Wall Street expectations. The positive market reaction reflected management’s ability to navigate significant headwinds, particularly an unexpected increase in uninsured patient volumes following the expiration of enhanced premium tax credits. CEO Samuel N. Hazen highlighted that while overall patient demand remained robust—especially for emergency services—unfavorable payer mix shifts

July 29 () - GE HealthCare on Wednesday beat Wall Street estimates for second-quarter profit, helped by strong demand for its ‌diagnostic and imaging devices and refunds of tariffs imposed under U. Shares of the medical device maker rose 12% in premarket trading.

HCA Healthcare (HCA), the United States' largest hospital chain, beat Wall Street on both revenue and profit for the second quarter, then watched its own stock fall anyway. The reason sits inside a single line item: a roughly $400 million pre-tax hit tied to patients losing health insurance ...

THC raised its 2026 outlook after Q2 earnings and revenues beat expectations, driven by strong same-facility growth and disciplined expense management.

HCA Healthcare's (HCA) Q2 results were largely in line with the company's pre-release but Health Ins

People formerly covered by the ACA exchanges are remaining uninsured almost on a one for one basis. “For us, obviously, it’s not a good thing,” CEO Sam Hazen said.

Independent monitors flagged recurring non-compliance issues tied to HCA Healthcare's acquisition of Mission Health for a third consecutive year. Concerns include discontinued industrial rehabilitation services, reduced access to services at Mission Hospital and affiliated facilities, and a Medicare termination notice. The findings focus attention on operational, regulatory, and reputational risks for NYSE:HCA as it manages this acquired network. HCA Healthcare, one of the largest for...

Moby summary of HCA Healthcare, Inc.'s Q2 2026 earnings call

A number of stocks fell in the morning session after concerns grew over a rising number of uninsured patients. The trend was highlighted in HCA Healthcare's recent earnings report, which pointed to a 'negative payer mix shift.' This term refers to a change in the types of insurance patients have, in this case, an increase in uninsured individuals resulting from losses in health insurance exchange coverage. For HCA, this shift was significant, reducing pre-tax income by an estimated $400 million

Despite strong earnings growth and strategic investments, HCA Healthcare Inc (HCA) faces headwinds from payer mix shifts and declining elective surgeries.

HCA Healthcare (NYSE:HCA) said its second-quarter performance reflected solid demand in several service lines and 11% growth in diluted earnings per share, but the company faced increased financial pressure as patients losing health insurance exchange coverage shifted largely into the uninsured popu

HCA tops Q2 EPS estimates on higher admissions and revenue per admission but trims parts of its 2026 guidance as higher expenses and weaker surgical volumes weigh on results.

Tenet and HCA Healthcare present Wall Street with different pictures of their operations as the companies report second-quarter earnings.

While the top- and bottom-line numbers for HCA (HCA) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

HCA (HCA) delivered earnings and revenue surprises of +0.26% and 0.00%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Hospital operator HCA Healthcare (NYSE:HCA) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 8.7% year on year to $20.23 billion. The company expects the full year’s revenue to be around $78.25 billion, close to analysts’ estimates. Its GAAP profit of $7.62 per share was 2.2% above analysts’ consensus estimates.

The benchmark US stock measures were trending higher before the open Friday as investors assess Wash

Today Earnings: American Express, Verizon, Charter Communications, HCA Healthcare, Volkswagen, Canadian National Railway Economic data: Commerce Department data on new home sales for June, S&P flash U.

Today Earnings (a.m.): American Airlines, Blackstone, Lockheed Martin, Comcast, RTX, PG&E, T-Mobile Earnings (p.m.): Intel Central banks: The European Central Bank announces its interest-rate decision.

Hospital operator HCA Healthcare (NYSE:HCA) will be announcing earnings results this Friday morning. Here’s what to expect.

Avantor (AVTR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Today Earnings: AT&T, GE Vernova, PulteGroup, CME Group, Moody’s, Philip Morris International Earnings (p.m.): Alphabet, Tesla, IBM, Southwest Airlines, Texas Instruments, CSX, ServiceNow, Raymond James Economic data: The Energy Information Administration will release its weekly petroleum status report.

Today Earnings (a.m.): General Motors, Charles Schwab, Danaher, 3M, Equifax, Hasbro, Northrop Grumman, Halliburton Earnings (p.m.): Chubb, Capital One, Interactive Brokers Economic data: ADP weekly ...

HCA faces Q2 earnings uncertainty as rising expenses and fewer outpatient surgeries may offset admission growth.

Today Earnings (a.m.): Domino’s Pizza, AMC Entertainment Holdings Earnings (p.m.): Steel Dynamics Economic data: U.S. leading economic indicators report for June Tomorrow Earnings: General Motors, ...

Intuitive Surgical shares fell about 10% after Q2 2026 revenue rose 19% but guidance for da Vinci procedure growth wasn't raised, pushing ISRG below its 200-week moving average.

Check out the companies making headlines this week:

CareDx (CDNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

GE HealthCare Technologies (GEHC) is back in focus after a new research collaboration with Mayo Clinic on the MI-BET theranostics trial for advanced prostate cancer, highlighting its molecular imaging and radioligand therapy capabilities. See our latest analysis for GE HealthCare Technologies. At a recent share price of US$63.20, GE HealthCare Technologies has seen the share price fall 13.66% over the past 90 days and the 1-year total shareholder return decline 16.09%, as investors reacted to...

HCA Healthcare stock has fallen sharply in the short term, yet over five years it is still in positive territory and currently screens as undervalued on several valuation checks. This sets up a clear tension between recent sentiment and longer term returns. HCA Healthcare has returned 52.3% over the past five years, so long term holders remain ahead even after recent share price pressure. Expectations around HCA Healthcare’s use of scale and AI tools to support care quality can help the...

Elevance Health topped Q2 earnings estimates Wednesday, despite falling medical membership, but profit was boosted by one-time "below-the-line" factors and the full-year outlook was underwhelming. ELV stock tumbled, making it among the S&P 500's early laggards. Molina Healthcare, another S&P 500 managed care stock, joined Elevance among the biggest laggards performers in pre-market trading.

HCA Healthcare is in focus after its modeled fair value was trimmed from US$503.57 to US$490.29, reflecting updated assumptions in the latest analyst work. This shift lines up with recent research that leans more cautious on long term growth and policy risk, even as some analysts still point to support from core operations and certain volume trends. As you read on, you will see how these pricing updates fit into the broader Street narrative on HCA Healthcare and what to watch to keep up with...

HCA Healthcare, Inc. (NYSE:HCA) is one of the top cheap blue chip stocks to buy according to Wall Street analysts. Barclays downgraded HCA Healthcare, Inc. (NYSE:HCA) to Equal Weight from Overweight on July 8, bringing the price target on the stock down to $427 from $496. The firm told investors that following a strong three-year […]

In July 2026, HCA Healthcare, Inc. reported preliminary second-quarter 2026 results showing revenue of about US$20.23 billion and net income of about US$1.70 billion, while also lowering its full-year 2026 earnings guidance due to a payer mix shift toward more uninsured patients following changes in health insurance exchange coverage. An important nuance is that HCA expects an unfavorable impact on income before taxes from this payer mix shift, only partly offset by incremental benefits from...

Shares of hospital management company Universal Health Services (NYSE:UHS) fell 5.5% in the afternoon session after the company faced pressure from a sharp jump in nursing shortages and broader industry concerns as peer HCA Healthcare cut its profit forecast.

Shares of hospital operator Tenet Healthcare (NYSE:THC) fell 7% in the afternoon session after its stock was dragged down by a sector-wide sell-off as industry peer HCA Healthcare cut its full-year 2026 profit forecast.

Intuitive Surgical stock tumbled Tuesday after HCA Healthcare trimmed its full-year earnings outlook, noting a drop in surgeries.

Healthcare stocks fell late Tuesday afternoon with the NYSE Healthcare Index declining 1.7% and the

Shares of hospital operator HCA Healthcare (NYSE:HCA) fell 6.7% in the morning session after the company released preliminary second-quarter results and cut its full-year 2026 profit guidance.

The company attributed the guidance cut to a larger-than-expected shift in payer mix and a greater financial impact from health insurance exchanges.

HCA Healthcare stock falls after the hospital chain operator lowers its full-year profit outlook as uninsured patients rise in the second quarter.

HCA Healthcare Inc.’s (NYSE:HCA) stock is trading lower on Tuesday after cutting its fiscal 2026 earnings guidance from $29.10-$31.50 to $28.70-$30.50. The company also narrowed its 2026 sales guidance from $76.5 billion-$80 billion to $77 billion-$79.5 billion, versus the consensus of $78.643 billion. After the update, the stock fell around 10% during the premarket session. The hospital operator reported preliminary second-quarter revenue of approximately $20.23 billion, up from $18.61 billion

HCA Healthcare, Inc. (NYSE:HCA) released preliminary second-quarter 2026 financial results while reducing its full-year earnings outlook, as a growing number of uninsured patients weighed on profitability following changes in health insurance exchange coverage.

The for-profit operator of healthcare facilities scaled back financial guidance for the year following payer mix shifts due to health insurance exchanges.

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3%, and the actively tra

Payer mix changes, mostly from people dropping out of Affordable Care Act plans, caused HCA to lose $400 million in the second quarter — much more than the company (or its investors) had expected.